Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Almeria – page 2

62 clinical trials in Almeria, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Almeria at a glance
62
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

62 trials in Almeria

Open in trial search

A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:ADS-019
  • Sponsor:Sarepta Therapeutics Inc.

A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Fundacion PETHEMA

HIV infection

Recruiting

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir Sodium
  • Sponsor:Viiv Healthcare UK Limited

Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Para La Investigacion Biomedica De Cordoba

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Bullous impetigo+3

Recruiting

Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Sponsor:Laboratorios Ojer Pharma S.L.

Hepatitis D

Recruiting

Clinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BJT-778
  • Sponsor:Mirum Pharmaceuticals Inc.

Study on the Safety and Effectiveness of Sovateltide for Patients with Acute Ischemic Stroke

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sovateltide
  • Sponsor:Pharmazz EU Limited

IgA nephropathy

Recruiting

Study on Ravulizumab for Children with IgA Nephropathy (Ages 2-17)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.

Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Grupo Espanol Multidisciplinar De Melanoma
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atacicept
  • Sponsor:Vera Therapeutics Inc.

Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Almeria

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on coronary artery disease and innovative treatments for atherosclerotic cardiovascular disease. Studies evaluating new antiplatelet therapies and investigating treatments for spontaneous coronary artery dissection.

  • Antiplatelet therapy optimization
  • Cardiovascular risk reduction
  • Arterial disease management
02 Metabolic Disorders

Investigations into treatments for Type 2 Diabetes Mellitus and obesity management. Studies evaluating novel medications for weight control and metabolic regulation in patients with weight-related comorbidities.

  • Diabetes management
  • Weight control therapies
  • Metabolic regulation
03 Infectious Diseases

Research on HIV treatment optimization and innovative therapies for various bacterial infections. Studies examining antibiotic treatment durations for enterococcal infections and other bacterial conditions.

  • HIV antiretroviral therapy
  • Bacterial infection management
  • Antifungal treatments
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.